医学
尿潴留
抗胆碱能
膀胱过度活动
抗胆碱药
泌尿科
神经源性膀胱功能障碍
兴奋剂
内科学
麻醉
膀胱
病理
替代医学
作者
Ryuji Sakakibara,Setsu Sawai,Tsuyoshi Ogata
出处
期刊:PubMed
日期:2023-05-01
卷期号:75 (5): 623-629
标识
DOI:10.11477/mf.1416202388
摘要
Urinary dysfunction includes an overactive bladder (OAB), post-void residual (PVR)/retention, or both entities. Brain diseases cause OAB, peripheral neuropathies are associated with significant PVR/retention, and multisystem atrophy/spinal cord diseases result in a combination of OAB and PVR/retention. Selective beta 3 adrenergic receptor agonists or anticholinergic agents are the first-choice treatment for OAB and clean intermittent self-catheterization, alpha-blocker and cholinergic stimulant therapy for significant PVR/retention. These therapies may be useful to maximize patients' quality of life and prevent serious complications, such as urosepsis or kidney dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI